Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors

Bert Vogelstein, Eric R. Fearon, Stanley R. Hamilton, Andrew P. Feinberg

Research output: Contribution to journalArticle

Abstract

A novel strategy to determine the clonal origin of human tumors has been devised. The strategy involves the use of a cloned polymorphic X-chromosomal gene and two restriction endonucleases. The first endonuclease distinguishes the paternal and maternal copies of the gene through a DNA polymorphism of restriction fragment length. The second endonuclease distinguishes active from inactive copies of this gene through changes in DNA methylation. As illustrations of this strategy, three human cancers were each shown to be monoclonal. The analysis described should have a wide variety of clinical and experimental applications.

Original languageEnglish (US)
Pages (from-to)642-645
Number of pages4
JournalScience
Volume227
Issue number4687
DOIs
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors'. Together they form a unique fingerprint.

  • Cite this